(Q35796653)

English

Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial

scientific article published on 2 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

fatty liver disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

author name string

Abbaszadeh Sepideh

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Parastouei Karim

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Afshari Hossein

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Rostami Leila

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mahmoudi Hamdollah

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ghamarchehreh Mohammad E

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sepandi Mojtaba

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Samadi Mohammad

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ghanizadeh Ghader

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Alavian Seyed Moayed

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

2 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Journal of the American College of Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

500-505

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Type and cause of liver disease in Korea: single-center experience, 2005-2010.

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Liver Transplantation for Quality as well as Quantity of Life

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

To evaluate the antigingivitis and antipalque effect of an Azadirachta indica (neem) mouthrinse on plaque induced gingivitis: A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2015.1031355

21 January 2018

Identifiers

10.1080/07315724.2015.1031355

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

release_2hceqyh4ovf5ndhu2tggjrpzfq

1 reference

https://api.fatcat.wiki/v0/release/2hceqyh4ovf5ndhu2tggjrpzfq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35796653&oldid=1840201339"